Teva Canada welcomes the recent announcement from Québec's Ministry of Health regarding changes to the reimbursement ...

Teva Pharmaceutical Industries is able to absorb any potential tariffs imposed by the Trump administration, the company said ...

In its third quarter, Teva booked revenue of $4.48 billion. That was 3% higher year over year, and much of that growth came ...

Teva Pharmaceutical Industries reported on Wednesday a higher-than-expected rise in third-quarter profit, helped by strong ...

Teva Pharmaceutical Industries Ltd (TEVA) reports its 11th consecutive quarter of growth, driven by innovative products, ...

Teva shares jumped 12% after Q3 earnings beat estimates, driven by strong branded drug sales led by Austedo and solid guidance for 2025.

Teva CEO Richard Francis said, "Following the conclusion of the IRA pricing negotiations, we are reiterating our strong ...

This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD’ campaignTD is a ...

Teva Pharmaceutical Industries Limited ( ($TEVA) ) has released its Q3 earnings. Here is a breakdown of the information Teva Pharmaceutical ...

Key Points Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund ...

Jefferies London Healthcare Conference Tuesday, November 18, 2025, at 11:00 A.M. Greenwich Mean Time (6:00 A.M. ET) To access a live webcast of the presentation, visit Teva’s Investor Relations ...

For an accessible version of this Press Release, please visit reports revenues of $4.5 billion in the third quarter of ...